UnitedHealth Group Incorporated (NYSE:UNH) Stake Reduced by Winthrop Advisory Group LLC

Winthrop Advisory Group LLC reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,270 shares of the healthcare conglomerate’s stock after selling 54 shares during the quarter. Winthrop Advisory Group LLC’s holdings in UnitedHealth Group were worth $742,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of UNH. Kathleen S. Wright Associates Inc. purchased a new position in UnitedHealth Group in the third quarter valued at about $27,000. Macroview Investment Management LLC increased its holdings in UnitedHealth Group by 671.4% in the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after buying an additional 47 shares during the last quarter. Delos Wealth Advisors LLC grew its position in UnitedHealth Group by 757.1% in the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after acquiring an additional 53 shares in the last quarter. Bbjs Financial Advisors LLC bought a new stake in UnitedHealth Group in the second quarter worth $31,000. Finally, Global Wealth Strategies & Associates raised its holdings in UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after buying an additional 32 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

NYSE:UNH opened at $605.45 on Friday. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $608.63. The firm has a market capitalization of $557.18 billion, a price-to-earnings ratio of 39.44, a P/E/G ratio of 1.75 and a beta of 0.58. The stock’s 50 day moving average price is $581.13 and its two-hundred day moving average price is $543.74. The company has a quick ratio of 0.88, a current ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. During the same period in the prior year, the firm earned $6.56 EPS. The business’s revenue was up 9.2% on a year-over-year basis. On average, analysts anticipate that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.39%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.72%.

Wall Street Analyst Weigh In

Several equities analysts have commented on UNH shares. Royal Bank of Canada lowered their price target on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a report on Wednesday, October 16th. Jefferies Financial Group upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $481.00 to $647.00 in a research note on Wednesday, July 17th. Wells Fargo & Company increased their price objective on UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a research report on Wednesday, July 17th. KeyCorp initiated coverage on shares of UnitedHealth Group in a report on Friday, October 11th. They set an “overweight” rating and a $675.00 price objective on the stock. Finally, StockNews.com downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 24th. Four analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group has an average rating of “Moderate Buy” and an average target price of $615.53.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.